IL17A and infection: ELISA tests of the cytokines in the mouse serum showed that ETBF infection did increase levels of IL-17A in the pro-inflammatory cytokine compared with the uninfected group, the vaccine treatment after ETBF infection reduced IL-17A level to some extent (Fig. S12D), indicating the vaccine may mitigate the pro-inflammatory response caused by ETBF.